Technical Analysis for CRTX - Cortexyme, Inc.

Grade Last Price % Change Price Change
grade F 23.17 0.43% 0.10
CRTX closed up 0.43 percent on Thursday, October 17, 2019, on 20 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Flat
See historical CRTX trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.43%
NR7 Range Contraction 0.43%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.74%
MACD Bullish Signal Line Cross Bullish -1.74%
Up 3 Days in a Row Strength -1.74%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.28%
Narrow Range Bar Range Contraction -1.28%

Older signals for CRTX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
CRTX Chart by TradingView
Basic chart:
Profile
Cortexyme is a clinical stage pharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat a key underlying cause of Alzheimer's disease and other degenerative diseases. Cortexyme is targeting a specific, infectious pathogen found in the brain of Alzheimer’s patients and tied to neurodegeneration and neuroinflammation in animal models. The company's lead investigational medicine, COR388, is the subject of the GAIN Trial, an ongoing Phase 2/3 clinical study in patients with mild to moderate Alzheimer’s.
Medical Specialties Organ Systems Alzheimer's Disease Nervous System Degenerative Diseases Neurology Stage Pharmaceutical
Is CRTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Oct 9 Top Ranked Momentum Stocks to Buy for October 9th
Oct 7 Did Cortexyme, Inc. (NASDAQ:CRTX) Insiders Buy Up More Shares?
Sep 26 Cortexyme launches screening in Europe for Alzheimer's study of COR388
Sep 26 Cortexyme Announces European Screening Now Underway in the Phase 2/3 GAIN Trial
Sep 23 Top Ranked Momentum Stocks to Buy for September 23rd
Aug 8 What Percentage Of Cortexyme, Inc. (NASDAQ:CRTX) Shares Do Insiders Own?
Jul 31 Cortexyme to Present at the Canaccord Genuity Growth Conference on August 7th
Jul 17 Cortexyme’s Approach to Addressing a Key Underlying Cause of Alzheimer’s Detailed at Alzheimer’s Association International Conference 2019
Jul 12 Key events next week - healthcare
Jul 10 Cortexyme Announces Upcoming Data Presentations at the Alzheimer’s Association International Conference 2019
See more CRTX news...
Indicators
Indicator Value
52 Week High 47.5
52 Week Low 19.35
Average Volume 36,826
200-Day Moving Average 0.0
50-Day Moving Average 24.686
20-Day Moving Average 24.1965
10-Day Moving Average 23.195
Average True Range 1.6583
ADX 21.34
+DI 14.7175
-DI 23.562
Chandelier Exit (Long, 3 ATRs ) 23.6451
Chandelier Exit (Short, 3 ATRs ) 26.9749
Upper Bollinger Band 27.2143
Lower Bollinger Band 21.1787
Percent B (%b) 0.33
BandWidth 24.944103
MACD Line -0.699
MACD Signal Line -0.7357
MACD Histogram 0.0367
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.77
Resistance 3 (R3) 23.75 23.52 23.67
Resistance 2 (R2) 23.52 23.37 23.54 23.64
Resistance 1 (R1) 23.35 23.28 23.44 23.37 23.60
Pivot Point 23.12 23.12 23.17 23.14 23.12
Support 1 (S1) 22.95 22.97 23.04 22.97 22.74
Support 2 (S2) 22.72 22.88 22.74 22.70
Support 3 (S3) 22.55 22.72 22.67
Support 4 (S4) 22.57